4//SEC Filing
Brenner Randall B. 4
Accession 0000904454-22-000623
CIK 0001178711other
Filed
Dec 13, 7:00 PM ET
Accepted
Dec 14, 8:03 PM ET
Size
7.6 KB
Accession
0000904454-22-000623
Insider Transaction Report
Form 4
Brenner Randall B.
Chief Development & Regulatory
Transactions
- Sale
Common Stock
2022-12-13$1.96/sh−18,177$35,627→ 324,851 total - Sale
Common Stock
2022-12-12$1.98/sh−11,105$21,988→ 343,028 total
Footnotes (3)
- [F1]Sale of shares to cover personal income tax obligations upon vesting of restricted stock unit awards, pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $1.96 to $2.00. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2 to this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $1.93 to $2.01. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 3 to this Form 4.
Documents
Issuer
Paratek Pharmaceuticals, Inc.
CIK 0001178711
Entity typeother
Related Parties
1- filerCIK 0001788249
Filing Metadata
- Form type
- 4
- Filed
- Dec 13, 7:00 PM ET
- Accepted
- Dec 14, 8:03 PM ET
- Size
- 7.6 KB